Results 161 to 170 of about 6,228,391 (354)

Cytosolic Tissue-Type Plasminogen Activator (T-Pa) Levels in Breast Tumors and Hormone Dependence. Role of Ps2

The International Journal of Biological Markers, 1994
A. Ruibal, A. Alvarez, B. Fernández Llana, Ma Fernández Fernández, Ma C. Roiz, Ma T. Allende   +5 more
doaj   +1 more source

A Genome-Scan Method to Identify Selected Loci Appropriate for Both Dominant and Codominant Markers: A Bayesian Perspective

Genetics, 2008
M. Foll, O. Gaggiotti
semanticscholar   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source

CA125 Serum levels in tubercolosis patients

The International Journal of Biological Markers, 1995
J. Fernández B. De Quirós, M. Telenti, P. Suarez Leiva, B. Fernández Llana, M. T. Allende, A. Ruibal Morell   +5 more
doaj   +1 more source

Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes

Proceedings of the National Academy of Sciences of the United States of America, 2016
J. Kowal, Guillaume Arras, Marina Colombo, M. Jouve, Jakob Paul Morath, Bjarke Primdal-Bengtson, F. Dingli, D. Loew, M. Tkach, C. Théry   +9 more
semanticscholar   +1 more source

Going Beyond “Bio-markers,” Think “Life-markers” [PDF]

Chest, 2020
Laren Tan, Geoff Chupp, Mario Castro, Monica Kraft   +3 more
openaire   +2 more sources

A synthetic benzoxazine dimer derivative targets c‐Myc to inhibit colorectal cancer progression

Molecular Oncology, EarlyView.
Benzoxazine dimer derivatives bind to the bHLH‐LZ region of c‐Myc, disrupting c‐Myc/MAX complexes, which are evaluated from SAR analysis. This increases ubiquitination and reduces cellular c‐Myc. Impairing DNA repair mechanisms is shown through proteomic analysis.
Nicharat Sriratanasak, Bodee Nutho, Worawat Wattanathana, Narumon Phaonakrop, Bunnatut Panasawatwong, Katharina Erlenbach‐Wuensch, Sittiruk Roytrakul, Regine Schneider‐Stock, Pithi Chanvorachote   +8 more
wiley   +1 more source

Richness of human gut microbiome correlates with metabolic markers

Nature, 2013
E. Chatelier, T. Nielsen, J. Qin, Edi Prifti, F. Hildebrand, G. Falony, Mathieu Almeida, Manimozhiyan Arumugam, Jean-Michel Batto, S. Kennedy, Pierre Leonard, Junhua Li, K. Burgdorf, N. Grarup, T. Jørgensen, I. Brandslund, H. Nielsen, A. S. Juncker, Marcelo Bertalan, F. Levenez, N. Pons, Simon Rasmussen, S. Sunagawa, J. Tap, S. Tims, E. Zoetendal, S. Brunak, K. Clément, J. Doré, M. Kleerebezem, K. Kristiansen, P. Renault, Thomas Sicheritz-Pontén, W. M. Vos, Jean-Daniel Zucker, J. Raes, T. Hansen, P. Bork, Jun Wang, S. Ehrlich, O. Pedersen   +40 more
semanticscholar   +1 more source

Adaptaquin is selectively toxic to glioma stem cells through disruption of iron and cholesterol metabolism

Molecular Oncology, EarlyView.
Adaptaquin selectively kills glioma stem cells while sparing differentiated brain cells. Transcriptomic and proteomic analyses show Adaptaquin disrupts iron and cholesterol homeostasis, with iron chelation amplifying cytotoxicity via cholesterol depletion, mitochondrial dysfunction, and elevated reactive oxygen species.
Adrien M. Vaquié, Davod R. Shah, Eliane E. S. Brechbühl, Michael McNicholas, Zhaoyang Xu, John H. Stockley, Laura Morcom, Diana Gold Diaz, Gemma C. Girdler, Rachel V. Seear, Gabriel Balmus, Rajiv R. Ratan, Harry Bulstrode, James A. Nathan, Manav Pathania, Kevin M. Brindle, David H. Rowitch   +16 more
wiley   +1 more source

TPS cytosolic levels in non-malignant breast diseases

The International Journal of Biological Markers, 1995
A. Alvarez, P.I. Martinez Rodriguez, M.I. Nuñez, A. Alba, M.T. Allende, A. Ruibal Morell   +5 more
doaj   +1 more source